Brief: Tarsus Welcomes Kate Goodrich, M.D., MHS, To Its Board Of Directors
13/11/2024 14:00
Nov 13 (Reuters) - Tarsus Pharmaceuticals Inc TARS.O :
* TARSUS WELCOMES KATE GOODRICH, M.D., MHS, TO ITS BOARD OF
DIRECTORS
Source text: ID:nGNX2dWprL
Further company coverage: TARS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tarsus Pharmaceuticals
See all newsBrief: Lisata Therapeutics Appoints Jeff Farrow To Board Of Directors
Brief: Tarsus Pharmaceuticals Files For Offering Of Up To 2.91 Million Shares Of Common Stock By Selling Stockholders
U.S. RESEARCH ROUNDUP-Argan, Mastec, Oracle
Tarsus Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Tarsus to expand eye disease pipeline with up to $800 million Alkeus acquisition (updated)